Unilateral nephrectomy versus renal arterial embolization and technique survival in peritoneal dialysis patients with autosomal dominant polycystic kidney disease

Author:

Pierre Malika1,Moreau Karine2,Braconnier Antoine1,Kanagaratnam Lukshe3,Lessore De Sainte Foy Célia4,Sigogne Mikael1,Béchade Clémence5,Petrache Andréea1,Verger Christian6ORCID,Frimat Luc7,Duval-Sabatier Ariane8,Caillard Sophie9,Halin Pascale10,Touam Malick11,Issad Belkacem12,Vrtovsnik François13,Petitpierre François14,Lobbedez Thierry5,Touré Fatouma115

Affiliation:

1. Department of Nephrology, CHU Reims, Reims, France

2. Department of Nephrology, CHU Bordeaux, Bordeaux, France

3. Department of Statistical Methodology, CHU Reims, Reims, France

4. Department of Nephrology, CHU Lille, Lille, France

5. Department of Nephrology, CHU Caen, Caen, France

6. Registre de dialyse peritoneale de langue française, Pontoise, France

7. Department of Nephrology, CHU Nancy, Vandœuvre-lès-Nancy, France

8. Department of Nephrology, CHU Marseille, Marseille, France

9. Department of Nephrology, CHU Strasbourg, Strasbourg, France

10. Department of Nephrology, CH Charleville-Mézières, Charleville-Mézières, France

11. Department of Nephrology, CHU Necker-enfants-malades, Paris, France

12. Department of Nephrology, CHU Pitié-Salpêtrière, Paris, France

13. Department of Nephrology, CHU Bichat, Paris, France

14. Department of Radiology, CHU Bordeaux, Bordeaux, France

15. Department of Nephrology, CHU Limoges, Limoges, France

Abstract

Abstract Background Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disorder associated with progressive enlargement of the kidneys and liver. ADPKD patients may require renal volume reduction, especially before renal transplantation. The standard treatment is unilateral nephrectomy. However, surgery incurs a risk of blood transfusion and alloimmunization. Furthermore, when patients are treated with peritoneal dialysis (PD), surgery is associated with an increased risk of temporary or definitive switch to haemodialysis (HD). Unilateral renal arterial embolization can be used as an alternative approach to nephrectomy. Methods We performed a multicentre retrospective study to compare the technique of survival of PD after transcatheter renal artery embolization with that of nephrectomy in an ADPKD population. We included ADPKD patients treated with PD submitted to renal volume reduction by either surgery or arterial embolization. Secondary objectives were to compare the frequency and duration of a temporary switch to HD in both groups and the impact of the procedure on PD adequacy parameters. Results More than 700 patient files from 12 centres were screened. Only 37 patients met the inclusion criteria (i.e. treated with PD at the time of renal volume reduction) and were included in the study (21 embolized and 16 nephrectomized). Permanent switch to HD was observed in 6 embolized patients (28.6%) versus 11 nephrectomized patients (68.8%) (P = 0.0001). Renal artery embolization was associated with better technique survival: subdistribution hazard ratio (SHR) 0.29 [95% confidence interval (CI) 0.12–0.75; P = 0.01]. By multivariate analysis, renal volume reduction by embolization and male gender were associated with a decreased risk of switching to HD. After embolization, a decrease in PD adequacy parameters was observed but no embolized patients required temporary HD; the duration of hospitalization was significantly lower [5 days [interquartile range (IQR) 4.0–6.0] in the embolization group versus 8.5 days (IQR 6.0–11.0) in the surgery group. Conclusions Transcatheter renal artery embolization yields better technique survival of PD in ADPKD patients requiring renal volume reduction.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Reference39 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3